Evolution Summit 2022 (B) | Marcus Evans | 12 September 2022 | Fairmont Grand Del Mar, 5300 Grand Del Mar Ct, San Diego, CA 92130, USA

This summit is an invitation-only, premium Summit bringing leading clinical trial executives and innovative suppliers and solution providers together. The Summit’s content is aligned with key clinical trial challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.

Key topics:
Exploring The Future Of Clinical Trials
• Finding the path forward post-Covid into decentralization and innovation

Optimizing Clinical Trials Design And Execution
• Maximizing the power of technology to reduce burden, risks, costs, and time

Understanding Regulatory Landscape Post Covid
• Local, federal and international laws impacting traditional and decentralized trials

Taking New Approaches To Patient Recruitment And Engagement
• Improving trials accessibility and communication to foster enrollment

Enhancing Outsourcing And Vendor Management Strategies
• Building smarter partnerships with sites and solution providers to improve outcomes

Facing Employee Turnover In Pharma And Healthcare Industries
• Strategies to face the great resignation, understand the labor market and win the talent war

2022 Speakers

Marie Rosenfeld
Senior Vice President, Head of Clinical Science, Astellas Pharma Inc.

COMPELLING PRESENTATIONS:

Craig Granowitz, M.D., Ph.D.
SVP and Chief Medical Officer, Lexicon Pharmaceuticals, Inc.

Josh Fessel, MD, PhD
Senior Clinical Advisor, Division of Clinical Innovation, National Center for Advancing Translational Sciences (NCATS)

John Linnell
State Captain, COPD Foundation and Patient Advocate

Padma Iyer, MSc
Associate Director, Clinical Operations, Daiichi Sankyo

David Vulcano
Honorary President, Society for Clinical Research Sites

COMPELLING PRESENTATIONS - LARGE PHARMA SPEAKERS:

Kelly Gash
Head of Clinical Operations, Oncology Early Development, AbbVie

Lilith Hayakawa Mist
Executive Director, Clinical Research, Global Clinical Trial Operations, Merck

Katie Doble
Advocate | Speaker | Writer | Cancer Survivor

INTERACTIVE SESSIONS:

Mary Spellman, M.D.
Chief Medical Officer and Senior Vice President of Research & Development, Castle Creek Biosciences

Jennifer Cook
Engagement Communications Manager, Duke Clinical Research Institute

Stephen Shrewsbury, MD
Chief Medical Officer, Impel Pharmaceuticals Inc.

Beth Metzheiser
Head of Clinical Operations, Hematology and CRO Collaborations, BMS

Cecilia Tran-Muchowski
Sr. Director in Clinical Operations, NGM Biopharmaceuticals

Susan Owen, M.S.
Vice President, Clinical Operations, Pliant

Jamielle Gibbs, MPH
Associate Director, Clinical Project Management, EQRx

Shwen Gwee
Former VP, Head of Global Digital Strategy, Bristol Myers Squibb

Kimberly Guedes, RN, BSN, MBA
Vice President, Clinical Operations, KeifeRx

Richard Ghalie
Chief Medical Officer, MEI Pharma

Deven V Parmar MD, FCP
Chief Medical Officer and Head, Clinical R&D, Zydus Therapeutics Inc

Adrian Di Bisceglie
Chief Medical Officer, HighTide Therapeutics

Jan Pieter Kappelle
Vice President Strategy, 4G Clinical

DYNAMIC MODERATOR:

John Makowski
Vice President, Head of Clinical Operations, Astellas Gene Therapies